Viral hepatitis burden in Europe
The HEPAHEALTH Project Report, produced by the European Association for the Study of the Liver (EASL), is the second overview commissioned by EASL on the burden of liver disease in Europe. The report encompasses…
DNA methylation related to liver disease among obese patients, study shows
Researchers have identified how DNA methylation is associated with a condition known as non-alcoholic fatty liver disease (NAFLD), which can lead to liver cirrhosis and death, and is one of the leading…
Predicting the future burden of NAFLD and NASH
While the prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) continues to rise, with both conditions increasingly recognised in primary care and specialist practice, quantifying future disease burden has…
Focused ultrasound increases drug delivery to liver tumours
A heat-sensitive liposomal preparation loaded with doxorubicin (multiple brands) was able to deliver its contents directly to liver lesions when the temperature was raised above 39.5 °C by focused ultrasound (FUS), according…
EASL Schools of Hepatology: The ‘flipped learning’ model
The traditional learning method which is lecture-based focuses primarily on allowing students to absorb knowledge in the classroom by listening and taking notes. Students are then expected to study the acquired material in…
Journal of Hepatology cited over 37,000 times in 2017
GENEVA, Switzerland 02 July 2018 – Last week Clarivate Analytics released the 2018 update of its Journal Citation Reports©, including the much anticipated 2017 impact factor. The Journal of Hepatology achieved exceptional results with…
Announcement of new Office Managing Director
EASL would like to announce that Laurence Verhagen has been appointed as the new Office Managing Director. Laurence Verhagen is an association management professional in the healthcare sector with an extensive track record in…